Role of Echocardiography in Detecting Left Ventricular Dysfunction Among Diabetic Patients: A Clinical and Biochemical Perspective

Echocardiography is a critical tool for early LVD detection, even in asymptomatic diabetic patients. Findings emphasize routine echocardiographic screening, particularly in those with diabetes duration ≥10 years, poor glycemic control (HbA1c >7%), or elevated hs-CRP levels, recommending assessments at least annually or sooner if symptoms arise. Managing glycemic and lipid profiles, alongside targeted inflammation-reducing strategies, such as anti-inflammatory pharmacologic interventions (e.g., statins, SGLT2 inhibitors, IL-6 inhibitors) and lifestyle modifications (diet, exercise, weight management), is essential for lowering cardiovascular risk. Integrating echocardiographic evaluation into routine diabetic care can help reduce the burden of diabetic cardiomyopathy and improve long-term cardiovascular outcomes.